Suppr超能文献

基于纳米技术的载有视黄醇棕榈酸酯的药物递送系统的局部应用用于治疗皮肤老化。

Topical application of retinyl palmitate-loaded nanotechnology-based drug delivery systems for the treatment of skin aging.

作者信息

Oliveira Marcela B, do Prado Alice Haddad, Bernegossi Jéssica, Sato Claudia S, Lourenço Brunetti Iguatemy, Scarpa Maria Virgínia, Leonardi Gislaine Ricci, Friberg Stig E, Chorilli Marlus

机构信息

Departament of Drugs and Pharmaceuticals, School of Pharmaceutical Sciences, UNESP, 14801-902 Araraquara, SP, Brazil.

Departament of Clinical Analysis, School of Pharmaceutical Sciences, UNESP, 14801-902 Araraquara, SP, Brazil, Brazil.

出版信息

Biomed Res Int. 2014;2014:632570. doi: 10.1155/2014/632570. Epub 2014 Mar 19.

Abstract

The objective of this study was to perform a structural characterization and evaluate the in vitro safety profile and in vitro antioxidant activity of liquid crystalline systems (LCS) with and without retinyl palmitate (RP). LCS containing polyether functional siloxane (PFS) as a surfactant, silicon glycol copolymer (SGC) as oil phase, and water in the ratios 30 : 25 : 45 and 40 : 50 : 10 with (OLS(v) = RP-loaded opaque liquid system and TLS(v) = RP-loaded transparent liquid system, respectively) and without (OLS and TLS, respectively) RP were studied. Samples were characterized using polarized light microscopy (PLM) and rheology analysis. In vitro safety profile was evaluated using red cell hemolysis and in vitro cytotoxicity assays. In vitro antioxidant activity was performed by the DPPH method. PLM analysis showed the presence of lamellar LCS just to TLS. Regardless of the presence of RP, the rheological studies showed the pseudoplastic behavior of the formulations. The results showed that the incorporation of RP in LCS improved the safety profile of the drug. In vitro antioxidant activity suggests that LCS presented a higher capacity to maintain the antioxidant activity of RP. PFS-based systems may be a promising platform for RP topical application for the treatment of skin aging.

摘要

本研究的目的是对含和不含棕榈酸视黄酯(RP)的液晶体系(LCS)进行结构表征,并评估其体外安全性和体外抗氧化活性。研究了以聚醚功能硅氧烷(PFS)为表面活性剂、硅二醇共聚物(SGC)为油相、水比例为30:25:45和40:50:10且含(分别为OLS(v)=负载RP的不透明液体体系和TLS(v)=负载RP的透明液体体系)和不含(分别为OLS和TLS)RP的LCS。使用偏光显微镜(PLM)和流变学分析对样品进行表征。通过红细胞溶血和体外细胞毒性试验评估体外安全性。采用DPPH法进行体外抗氧化活性测定。PLM分析表明仅TLS存在层状LCS。无论是否存在RP,流变学研究均表明制剂具有假塑性行为。结果表明,RP掺入LCS可改善药物的安全性。体外抗氧化活性表明LCS具有更高的维持RP抗氧化活性的能力。基于PFS的体系可能是用于治疗皮肤老化的RP局部应用的有前景的平台。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a1/3977527/16425021c817/BMRI2014-632570.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验